142 related articles for article (PubMed ID: 36505454)
1. Case report: Camrelizumab associated with central retinal vein occlusion.
Zhan Y; Zhao W; Ni K; Liu Z; Su Y; Li X; Zhang H; Zhang C
Front Immunol; 2022; 13():1025125. PubMed ID: 36505454
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
Zhang HR; Wang X; Lu XR; Yang YF; Liu F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
[TBL] [Abstract][Full Text] [Related]
3. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
4. Vitreous haemorrhage caused by unusual giant macular tear: a case report.
Lei C; Chen L
J Int Med Res; 2020 Sep; 48(9):300060520959493. PubMed ID: 32981397
[TBL] [Abstract][Full Text] [Related]
5. Combined central retinal vein occlusion and branch retinal artery occlusion treated with intravitreal dexamethasone implant: A case report.
Arrigo A; Knutsson KA; Rajabjan F; Augustin VA; Bandello F; Parodi MB
Eur J Ophthalmol; 2021 Mar; 31(2):NP74-NP76. PubMed ID: 32106703
[TBL] [Abstract][Full Text] [Related]
6. [Vitrectomy for vitreous hemorrhage caused by retinal vein occlusion].
Liu W; Wang W
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):113-5. PubMed ID: 11835787
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
8. Vitreous Hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion.
Browning DJ; Rotberg MH
Am J Ophthalmol; 1996 Oct; 122(4):588-9. PubMed ID: 8862064
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
Retina; 2005; 25(7):846-50. PubMed ID: 16205562
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion.
Amirikia A; Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ
Ophthalmology; 2001 Feb; 108(2):372-6. PubMed ID: 11158815
[TBL] [Abstract][Full Text] [Related]
13. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome.
Saika S; Tanaka T; Miyamoto T; Ohnishi Y
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):729-32. PubMed ID: 11760031
[TBL] [Abstract][Full Text] [Related]
14. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Jumper JM; Figueroa M;
Ophthalmology; 2009 Mar; 116(3):504-12. PubMed ID: 19167078
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion.
Udaondo P; Díaz-Llopis M; García-Delpech S; Salom D; Romero FJ
Arch Ophthalmol; 2011 Mar; 129(3):283-7. PubMed ID: 21402982
[TBL] [Abstract][Full Text] [Related]
17. Detection of underdiagnosed concurrent branch retinal artery occlusion in a patient with central retinal vein occlusion using spectral domain optical coherence tomography.
Karapetyan A; Ouyang P; Tang LS; Zeng J; Ying MD
BMC Ophthalmol; 2014 Jul; 14():91. PubMed ID: 25015220
[TBL] [Abstract][Full Text] [Related]
18. Delayed closure of macular hole secondary to Terson syndrome after vitrectomy: A case report and literature review.
Sheng Y; Sun W; Shen Y
Medicine (Baltimore); 2019 Aug; 98(31):e16577. PubMed ID: 31374025
[TBL] [Abstract][Full Text] [Related]
19. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.
Charbonnel J; Glacet-Bernard A; Korobelnik JF; Nyouma-Moune E; Pournaras CJ; Colin J; Coscas G; Soubrane G
Graefes Arch Clin Exp Ophthalmol; 2004 Mar; 242(3):223-8. PubMed ID: 14685873
[TBL] [Abstract][Full Text] [Related]
20. Off label intravitreal Brolucizumab in treatment of recurrent macular edema due to branch retinal vein occlusion: A case report.
Panigrahi PK
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102694. PubMed ID: 34921989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
